Plasma Proteomic Profiles of #AtopicDermatitis Patients with Moderate-to-Severe #Pruritus Treated with a Single Dose of #Nemolizumab https://ow.ly/i6et50YkXMM #dermsky

Efficacy and Safety of Nemolizumab in Patients With Prurigo Nodularis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials This meta-analysis evaluated the efficacy and safety of nemolizumab in treating prurigo nodularis through a systematic review of randomized controlled trials. A comprehensive literature search was con...

Prurigo Nodularis (PN) is notoriously difficult to treat. Can targeting the "itch cytokine" (IL-31) finally bring relief?

doi.org/10.7759/cureus.78761

#WeiPublications #DermSky #Dermatology #MedSky #PrurigoNodularis #Itch #Nemolizumab #FOAMed

Interleukin-31-Hemmer ▼Nemolizumab (NEMLUVIO) bei atopischer Dermatitis Der neue Antikörper hemmt IL-31 und stellt damit ein neues Wirkprinzip bei atopischer Dermatitis dar. Wieder einmal fehlen direkte Vergleiche mit anderen Therapien, da nur mit Placebo verglichen wird.

Interleukin-31-Hemmer #Nemolizumab (NEMLUVIO) bei atopischer Dermatitis
Der neue Antikörper stellt damit ein neues Wirkprinzip bei atopischer Dermatitis dar. Wieder einmal fehlen direkte Vergleiche mit anderen Therapien, da nur mit Placebo verglichen wird.
www.arznei-telegramm.de/html/2025_04...

Significance of Nemolizumab Approval for Atopic Dermatitis, with Raj Chovatiya, MD, PhD In this interview, Chovatiya highlighted the unmet needs of patients with atopic dermatitis and the ways in which nemolizumab’s FDA approval addresses them.

What is the significance of the FDA's approval of #nemolizumab for patients with #AtopicDermatitis?

🎥We sat down with Raj Chovatiya, MD, PhD, about the approval & the drug's impact among patients.

www.hcplive.com/view...